HBV infection in indigenous children, 20 years after immunization in Taiwan: A community-based study

Preventive Medicine

Volumn 48, Issue 4, 2009, Pages 397-400

  Huang, Chung Feng ^a,b   Dai, Chia Yen ^a,b   Chuang, Wan Long ^a,b   Ho, Chi Kung ^a   Wu, Ta Chung ^b   Hou, Nai Jen ^a,c   Wang, Chao Ling ^a   Hsieh, Ming Yen ^a   Huang, Jee Fu ^a,c   Lin, Zu Yau ^a,b   Chen, Shinn Cherng ^a,b   Hsieh, Ming Yuh ^a,b   Wang, Liang Yen ^a,b   Tsai, Jun Fa ^a,b   Chang, Wen Yu ^a,b   Yu, Ming Lung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

HBV; Indigenous population; Taiwan

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ADOLESCENT; ARTICLE; CHILD; COMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEALTH PROGRAM; HEPATITIS B; HUMAN; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE; TAIWAN; AGE; ETHNOLOGY; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOLOGY; RETROSPECTIVE STUDY; SEROLOGY;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; TAIWAN;

EID: 63449142586     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2009.02.002     Document Type: Article

References (32)

1. Alhababi F., Sallam T.A., and Tong C.Y. The significance of 'anti-HBc only' in the clinical virology laboratory. J. Clin. Virol. 27 (2003) 162-169
2. Carman W.F., Zanetti A.R., Karayiannis P., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336 (1990) 325-329
3. Chang M.H. Natural history of hepatitis B virus infection in children. J. Gastroenterol. Hepatol. 15 Suppl (2000) E16-E19
4. Chang M.H. Hepatitis B virus infection. Semin Fetal Neonatal Med. 12 (2007) 160-167
5. Chen D.S. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 262 (1993) 369-370
6. Chen D.S., and Sung J.L. Hepatitis B virus infection on Taiwan [letter]. N. Engl. J. Med. 297 (1997) 668-669
7. Chen D.S., Hsu N.H., Sung J.L., et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257 (1987) 2597-2603
8. Chung D.C., Ko Y.C., Chen C.J., et al. Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan. J. Med. Virol. 26 (1988) 411-418
9. Dai C.Y., Chuang W.L., Ho C.K., et al. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J. Hepatol. 49 (2008) 9-16
10. Fang J.W., Lai C.L., Chung H.T., Wu P.C., and Lau J.Y. Female children respond to recombinant hepatitis B vaccine with a higher titre than male. J. Trop. Pediatr. 40 (1994) 104-107
11. Hsu H.Y., Chang M.H., Hsieh K.H., et al. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology 15 (1992) 770-776
12. Hsu H.Y., Chang M.H., Ho H.N., et al. Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. Vaccine 11 (1993) 1437-1440
13. Hsu S.C., Chang M.H., Ni Y.H., Hsu H.Y., and Lee C.Y. Horizontal transmission of hepatitis B virus in children. J. Pediatr. Gastroenterol. Nutr. 16 (1993) 66-69
14. Hsu L.C., Lin S.R., Hsu H.M., et al. Ethnic differences in immune responses to hepatitis B vaccine. Am. J. Epidemiol. 143 (1996) 718-724
15. Hsu H.Y., Chang M.H., Liaw S.H., Ni Y.H., and Chen H.L. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30 (1999) 1312-1317
16. Huang M.L., Chiu L.Y., Pan W.H., Yang C.M., Hu C.Y., and Lin D.B. Negative association between HLA-A2 and a low antibody response to hepatitis B vaccine in Bunun ethnic children. J. Genet. Molec. Biol. 3 (2001) 151-160
17. Lee W.M. Hepatitis B virus infection. N. Engl. J. Med. 337 (1997) 1733-1745
18. Lin H.H., Wu J.S., Lu C.F., and Wong C.K. Hepatitis B virus infection among aboriginal children in eastern Taiwan. J. Formos Med. Assoc. 91 (1992) 691-693
19. Lin H.H., Li Y.H., Yu J.H., et al. Ethnic and geographic variations in the prevalence of hepatitis A, B and C among aboriginal villages in Hualien, Taiwan. Infection 28 (2000) 205-208
20. Lin Y.C., Chang M.H., Ni Y.H., Hsu H.Y., and Chen D.S. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J. Infect. Dis. 187 (2003) 134-138
21. Lin D.B., Lin J.B., Chen S.C., Yang C.C., Chen W.K., and Chen C.J. Seroepidemiology of hepatitis E virus infection among preschool children in Taiwan. J. Med. Virol. 74 (2004) 414-418
22. Lok A.S., and Lai C.L. A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children. Hepatology 8 (1988) 1130-1133
23. Lu S.N., Chen C.H., Chen T.M., et al. Hepatitis B virus infection in adolescents in a rural township-15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 24 (2006) 759-765
24. Ni Y.H., Huang L.M., Chang M.H., et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 132 (2007) 1287-1293
25. Pasko M.T., and Beam Jr. T.R. Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine. Am. J. Public Health 80 (1990) 590-593
26. Shaw Jr. F.E., Guess H.A., Roets J.M., et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 7 (1989) 425-430
27. Sung J.L., Chen D.C., Lai M.Y., Yu J.Y., Wang T.H., and Wang C.Y. Epidemiological study of hepatitis B virus in Taiwan. Chin. J. Gastroenterol. 1 (1984) 1-9
28. Tang J.R., Hsu H.Y., Lin H.H., Ni Y.H., and Chang M.H. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J. Pediatr. 133 (1998) 374-377
29. Ural O., and Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J. Infect. 43 (2001) 187-190
30. Wang Z., Zhang J., Yang H., et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J. Med. Virol. 71 (2003) 360-366
31. Wang L.Y., Hu C.T., Ho T.Y., and Lin H.H. Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area. Vaccine 24 (2006) 4427-4432
32. Weber B., Melchior W., Gehrke R., Doerr H.W., Berger A., and Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J. Med. Virol. 64 (2001) 312-319